Shanghai Mass Spectrometry Center, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
Rapid Commun Mass Spectrom. 2012 Nov 15;26(21):2555-62. doi: 10.1002/rcm.6369.
Peptidomics analysis of human serum is challenging due to the low abundance of serum peptides and interference from the complex matrix. This study analyzed the differentially expressed (DE) low molecular weight peptides in human serum integrating a DMPITC-based N-terminal isotope labeling technique with nano-liquid chromatography and matrix-assisted laser desorption/ionization mass spectrometry (nano-LC/MALDI-MS).
The workflow introduced a [d(6)]-4,6-dimethoxypyrimidine-2-isothiocyanate (DMPITC)-labeled mixture of aliquots from test samples as the internal standard. The spiked [d(0)]-DMPITC-labeled samples were separated by nano-LC then spotted on the MALDI target. Both quantitative and qualitative studies for serum peptides were achieved based on the isotope-labeled peaks.
The DMPITC labeling technique combined with nano-LC/MALDI-MS not only minimized the errors in peptide quantitation, but also allowed convenient recognition of the labeled peptides due to the 6 Da mass difference. The data showed that the entire research procedure as well as the subsequent data analysis method were effective, reproducible, and sensitive for the analysis of DE serum peptides.
This study successfully established a research model for DE serum peptides using DMPITC-based N-terminal isotope labeling and nano-LC/MALDI-MS. Application of the DMPITC-based N-terminal labeling technique is expected to provide a promising tool for the investigation of peptides in vivo, especially for the analysis of DE peptides under different biological conditions.
由于血清肽的含量低且基质复杂,因此对人血清中小分子肽的差异表达(DE)进行肽组学分析具有挑战性。本研究整合了基于 DMPITC 的 N 端同位素标记技术与纳升液相色谱-基质辅助激光解吸/电离质谱联用(nano-LC/MALDI-MS),分析了人血清中差异表达的低分子量肽。
该工作流程引入了由测试样品等分试样的[ d (6)]-4,6-二甲氧基嘧啶-2-异硫氰酸酯(DMPITC)标记混合物作为内标。用 nano-LC 分离加标[ d (0)]-DMPITC 标记的样品,然后将其斑点点在 MALDI 靶上。基于同位素标记峰,实现了血清肽的定量和定性研究。
DMPITC 标记技术与 nano-LC/MALDI-MS 相结合,不仅最小化了肽定量中的误差,而且由于 6 Da 的质量差异,还便于识别标记肽。数据表明,整个研究过程以及随后的数据分析方法对于 DE 血清肽的分析是有效、可重复和敏感的。
本研究成功建立了基于 DMPITC 的 N 端同位素标记和 nano-LC/MALDI-MS 用于 DE 血清肽的研究模型。DMPITC 基 N 端标记技术的应用有望为体内肽的研究提供一种有前途的工具,特别是在不同生物学条件下分析 DE 肽。